Nekton Capital’s Colgate-Palmolive CL Stock Holding History

Nekton Capital’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-424,574	Closed	-$32.7M	–	18
2023 Q2	$32.7M	Sell	424,574 -259,312	-38%	-$20.1M	5.36%	9
2023 Q1	$51.4M	Buy	+683,886	New	+$50.9M	8.58%	4

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nekton Capital's CL Position: Q3 2023 in Review

Nekton Capital sold out of Colgate-Palmolive (CL) in Q3 2023, closing a stake of 424,574 shares — an estimated $32.7M sold.

Nekton Capital first reported a position in CL in Q1 2023 and held it in 2 quarters. The position peaked at $51.4M in Q1 2023. 1,620 funds tracked by Wall St. Rank hold CL as of Q3 2023.

Nekton Capital reported no remaining Colgate-Palmolive position as of Q3 2023 after selling out during the quarter.
Nekton Capital sold 424,574 Colgate-Palmolive shares in Q3 2023, an estimated $32.7M.
Nekton Capital first reported a position in Colgate-Palmolive in Q1 2023 and held it in 2 quarters.
Nekton Capital's Colgate-Palmolive position peaked at $51.4M in Q1 2023.
1,620 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on Nekton Capital's 13F filing for Q3 2023, filed 14 Nov 2023.